COMPASSIONATE ACCESS PROGRAM
|
|
|
This website is intended for use by Australian healthcare professionals only (registration and verification is required) and is designed to comply with Australian law and regulations only. If you are a patient seeking medical advice, please contact your healthcare professional.
PBS INFORMATION: Authority Required (WRITTEN) for initial and first continuing prescriptions. Authority Required (STREAMLINED) for continuing subsequent prescriptions. Refer to PBS Schedule for full authority information.
AMGEVITA (adalimumab): Please review the full product information before prescribing available at www.amgen.com.au/Amgevita.PI or on request from Amgen Australia Pty Ltd. PH: 1800 803 638 OR medinfo.JAPAC@amgen.com
For more information on AMGEVITA or to report an adverse event or product complaint involving AMGEVITA please contact Amgen Medical Information on 1800 803 638 or email medinfo.JAPAC@amgen.com or visit www.amgenmedinfo.com.au
AU-16456. Date of Preparation: May 2022
